Evidence map›Paper›PMID 41936704›Full record

ArticleJournal of fluorescence2026

Functional Versatility of Sulfonamide-pyrazole Derivative: From Antibacterial Activity to Metal ion Sensing Aptitude.

Ankita Garg, Neha Garg, Rajat Dhiman, Savita Chaudhary, Aman Bhalla

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of fluorescence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ankita Garg *Department of Chemistry and Centre of Advanced Studies in Chemistry, Panjab University, Chandigarh, 160014, India.
Neha Garg *Department of Chemistry and Centre of Advanced Studies in Chemistry, Panjab University, Chandigarh, 160014, India.
Rajat DhimanDepartment of Chemistry and Centre of Advanced Studies in Chemistry, Panjab University, Chandigarh, 160014, India.
Savita ChaudharyDepartment of Chemistry and Centre of Advanced Studies in Chemistry, Panjab University, Chandigarh, 160014, India. schaudhary@pu.ac.in.
Aman BhallaDepartment of Chemistry and Centre of Advanced Studies in Chemistry, Panjab University, Chandigarh, 160014, India. amanbhalla@pu.ac.in.

Funding

DST IFACH-17Haryana State Council for Science and Technology HSCSIT/R&D/2020/476
6 · The paper itself

Abstract

In this study, a novel sulfonamide-Schiff base derivative, ethyl (Z)-2-(5-chloro-3-methyl-4-((2-tosylhydrazono) methyl)-1H-pyrazol-1-yl)acetate 6, was synthesized to address sulfonamide resistance and explore its therapeutic potential. The molecular structure was confirmed through comprehensive spectroscopic analyses including FT-IR, 1H & 13C NMR and mass spectrometry, providing strong evidence for the proposed architecture. Antibacterial evaluation revealed that compound 6 pyrazole exhibited notable antibacterial activity against Staphylococcus aureus (inhibition zones up to 1.2 mm), with comparatively moderate activity against Escherichia coli (0.6–0.7 mm). Molecular docking studies demonstrated pronounced binding affinities toward DNA gyrase and β-lactamase, corroborating its observed antibacterial efficacy and suggesting promising therapeutic relevance. Notably, the compound also displayed sensitive and selective chemosensing for Fe3+ (0.27 µM) and Fe2+ (0.12 µM), highlighting its multifunctional profile as both a potent antibacterial agent and a metal ion sensor. These findings indicate that compound 6 is a multifunctional bioactive scaffold and represents a promising lead for further investigation in antimicrobial and chemosensing applications.

Indexed as

Anti-Bacterial AgentsIronPyrazolesSulfonamidesEscherichia coliMicrobial Sensitivity TestsMolecular Docking SimulationMolecular StructureSchiff BasesStaphylococcus aureusStructure-Activity RelationshipAnti-Bacterial AgentsIronpyrazolePyrazolesSchiff BasesSulfonamidesantibacterialDNA gyrasepyrazoleSchiff basesulphonamideβ-lactamase

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.